Form 4 · MRK
Merck director Paul J. Diaz reports an award of about 613 phantom Stocks
Part of a grouped insider digest: see all related filings with totals →
Paul J. Diaz, a Merck director, filed a Form 4 on Nov 3, 2026 at 4:41 PM ET reporting transactions on Nov 1, 2026.
The filing reports about 613 phantom Stocks in a grant or award (code A).
Reporting person
- Paul J. Diaz, director (as filed: DIAZ PAUL J)
Transactions as reported
| Date | Code | Security | Shares | Price | Acquired or disposed | Held after | Ownership |
|---|---|---|---|---|---|---|---|
| 2026-11-01 | A | Phantom Stock (derivative) | 613 | $149.52 | Acquired | 613 | Direct |
Codes: P purchase, S sale, A grant or award, M/X/C exercise or conversion, F shares withheld for taxes or the exercise price, G gift. Prices are as reported; some are weighted averages of several trades.
Source
- Form 4 filed Nov 3, 2026 (document)
- Filing index on SEC EDGAR (all documents and exhibits)
Merck company file → · More Merck filings
Disclosures
- Editor holdings in MRK
- The editor holds no position in Merck (MRK). As of Nov 11, 2026.
- Last updated
- Nov 3, 2026
A summary of a public filing for general education, the same for every reader. Not a recommendation to buy, sell or hold MRK.